hkr.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
A health economic evaluation of follow up after breast cancer surgery: result from of an rct study
Kristianstad University, School of Health and Society.
Department of Oncology, University Hospital, Örebro.
Oncological center west health care region, University hospital, Gothenburg.
Department of surgical sciences, Uppsala University.
2008 (English)In: European Journal of Cancer Supplements, ISSN 1359-6349, Vol. 6, no 7, 167- p.Article in journal, Meeting abstract (Other academic) Published
Abstract [en]

Introduction: We studied the costs of following 264 breast cancer patients, stage I and II, randomised to two different follow-up programmes in a prospective trial, involving, on the one hand, routine follow-up visits to the physician with follow-up visits twice a year or more over five years (PG = physician group), and on the other, specialist nurse intervention with check-ups on demand (NG = nurse group). The trial period was 5 years. The women in the two intervention groups did not differ in anxiety and depression, their satisfaction with care, their experienced accessibility to the medical centre or their medical outcome as measured by recurrence or death.

Patients and Methods: The analyses were done from different lists representing costs at three hospitals in Sweden according to the principles of a cost minimization study. Result: The cost per person year of follow-up differed between the groups, with €630 per person year in PG compared to €495 per person year in NG. Thus, specialist nurse intervention with check-ups on demand was 20% less expensive than routine follow-up visits to the physician. The main difference in cost between the groups was explained by the numbers of visits to the physician in the respective study arms. There were 21% more primary contacts in PG than NG.

Discussion: The difference in cost per year and patient by study arm is modest, but transforms to nearly €9,000 per patient and 5-year period, offering a substantial opportunity for reallocating resources since breast cancer is the most prevalent tumour worldwide.

Place, publisher, year, edition, pages
2008. Vol. 6, no 7, 167- p.
Keyword [en]
Oncology, breast cancer, surgery
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:hkr:diva-59DOI: 10.1016/S1359-6349(08)70707-9ISI: 000256762000410OAI: oai:DiVA.org:hkr-59DiVA: diva2:132660
Note

Meeting abstract, 6th European Breast Cancer Conference Berlin, GERMANY, APR 15-19, 2008

Available from: 2008-12-23 Created: 2008-12-23 Last updated: 2012-11-20Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text
By organisation
School of Health and Society
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 108 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf